Antitrypanosomal activity of a new triazine derivative, SIPI 1029, in vitro and in model infections

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 10, 1998, Pages 2718-2721

  Bacchi, Cyrus J ^a   Vargas, Marcus ^a   Rattendi, Donna ^a   Goldberg, Burt ^a   Zhou, Weicheng ^b  

^a PACE UNIVERSITY   (United States)

^b SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITRYPANOSOMAL AGENT; MELARSOPROL; TRIAZINE DERIVATIVE; TRYBIZINE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; DRUG TOXICITY; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL; TRYPANOSOMIASIS;

EID: 0031664387     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.10.2718     Document Type: Article

References (19)

1. Bacchi, C. J., R. L. Berens, H. C. Nathan, R. S. Klein, I. A. Elegbe, K. V. B. Rao, P. P. McCann, and J. J. Marr. 1987. Synergism between 9-deazainosine and difluoromethylornithine in treatment of experimental African trypanosomiasis. Antimicrob. Agents Chemother. 31:1406-1413.
2. Bacchi, C. J., R. Brun, S. L. Croft, K. Alicea, and Y. Buhler. 1996. In vivo trypanocidal activities of new S-adenosylmethionine decarboxylase inhibitors. Antimicrob. Agents Chemother. 40:1448-1453.
3. Bacchi, C. J., J. Garofalo, M. A. Ciminelli, D. Rattendi, B. Goldberg, P. P. McCann, and N. Yarlett. 1993. Resistance to DL-α-difluoromethylornithine by clinical isolates of Trypanosoma brucei rhodesiense: role of S-adenosylmethionine. Biochem. Pharmacol. 46:471-481.
4. Bacchi, C. J., H. C. Nathan, T. Livingston, G. Valladares, M. Saric, P. D. Sayer, A. R. Njogu, and A. B. Clarkson, Jr. 1990. Differential susceptibility to DL-α-difluoromethylornithine in clinical isolates of Trypanosoma brucei rhodesiense. Antimicrob. Agents Chemother. 34:1183-1188.
5. Bacchi, C. J., H. C. Nathan, N. Yarlett, B. Goldberg, P. P. McCann, A. Sjoerdsma, and A. B. Clarkson, Jr. 1994. Combination chemotherapy of drug-resistant Trypanosoma brucei rhodesiense infections in mice using DL-α-difluoromethylornithine and standard trypanocides. Antimicrob. Agents Chemother. 38:563-569.
6. Bitonti, A. J., J. A. Dumont, and P. P. McCann. 1986. Characterization of Trypanosoma brucei brucei S-adenosyl-L-methionine decarboxylase and its inhibition by Berenil, pentamidine and methylglyoxal bis(guanylhydrazone). Biochem. J. 237:685-689.
7. Brun, R., Y. Buhler, U. Sandmeier, R. Kaminsky, C. J. Bacchi, D. Rattendi, S. Lane, S. L. Croft, D. Snowdon, V. Yardley, G. Caravatti, J. Frei, J. Stanek, and H. Mett. 1996. In vitro trypanocidal activities of new S-adenosylmethionine decarboxylase inhibitors. Antimicrob. Agents Chemother. 40:1442-1447.
8. Goldberg, B., N. Yarlett, J. Sufrin, D. Lloyd, and C. J. Bacchi. 1997. A unique transporter of S-adenosylmethionine in African trypanosomes. FASEB J. 11:256-260.
9. Hirumi, H., and K. Hirumi. 1989. Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers. J. Parasitol. 75:985-989.
10. Jennings, F. W., and A. R. Gray. 1983. Relapsed parasitemia following chemotherapy of chronic Trypanosoma brucei infections in mice and its relationship to cerebral trypanosomes. Contrib. Microbiol. Immunol. 7:147-154.
11. Knight, U. J., and W. Peters. 1980. The antimalarial activity of N-benzyloxydihydrotriazines. I. The activity of clociguanil (BRL50216) against rodent malaria, and studies on its mode of action. Ann. Trop. Med. Parasitol. 40: 393-404.
12. Knight, D. J., and R. J. Ponsford. 1982. Trypanocidal activity and prophylaxis evaluation of a series of bis-oxydihydrotriazines in mice. Ann. Trop. Med. Parasitol. 76:589-594.
13. Kuzoe, F. 1993. Current situation of African trypanosomiasis. Acta Trop. 54:153-162.
14. McKinley, J. C., Jr. 1997. Deadly epidemic emerges in Sudan. N. Y. Times 1997(18 July):A1.
15. Turner, W. R., and L. M. Werbel. 1985. Novel bis-(1.6-dihydro-6.6-dimethyl-1,3,5-triazine-2,4-diamines) as antitrypanosomal agents. J. Med. Chem. 28: 1728-1740.
16. Van Nieuwenhove, S. 1992. Advances in sleeping sickness therapy. Ann. Soc. Belge Med. Trop. 72(Suppl. 1):39-51.
17. World Health Organization. 1995. Tropical disease research. Twelfth programme report. World Health Organization, Geneva, Switzerland.
18. 3H]hypoxanthine into nucleic acid of Trypanosoma evansi. Chin. J. Vet. Parasitol. 1:10-12.
19. Zhou, W. C., Z. M. Xin, X. P. Zhang, J. Shen, and Q. P. Qiu. 1996. Synthesis and antiprotozoal activities of some new triazine derivatives including a new antitrypanosomal agent, SIPI-1029. Acta Pharm. Sin. 31:823-830.